We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy, Pfizer Settle Lipitor Dispute With License Agreement
Ranbaxy, Pfizer Settle Lipitor Dispute With License Agreement
June 18, 2008
Indian drugmaker Ranbaxy Laboratories has entered an agreement with Pfizer to settle most of the worldwide patent litigation involving the cholesterol drug Lipitor.